Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing's disease

European Journal of Endocrinology

Volumn 164, Issue 6, 2011, Pages 985-993

  Minetto, Marco A ^a,b   Lanfranco, Fabio ^a   Botter, Alberto ^b   Motta, Giovanna ^a   Mengozzi, Giulio ^c   Giordano, Roberta ^d   Picu, Andreea ^a   Ghigo, Ezio ^a   Arvat, Emanuela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b POLITECNICO DI TORINO   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MUSCLE PROTEIN; MYOGLOBIN; BIOLOGICAL MARKER; HYDROCORTISONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID INDUCED MYOPATHY; CREATINE KINASE BLOOD LEVEL; CUSHING DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; ELECTROMYOGRAPHY; FEMALE; HUMAN; HYPERCORTISOLISM; MALE; MUSCLE EXCITATION; MUSCLE FATIGUE; MUSCLE FIBER MEMBRANE CONDUCTANCE; MYOELECTRICITY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOLEMMA; TIBIALIS ANTERIOR MUSCLE; VASTUS LATERALIS MUSCLE; VASTUS MEDIALIS MUSCLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DOWN REGULATION; FOLLOW UP; MUSCLE FUNCTION; SENSITIVITY AND SPECIFICITY;

ANTHROPOMETRY; ATROPHY; CREATINE KINASE; CUSHING SYNDROME; ELECTRIC STIMULATION; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEURAL CONDUCTION; PILOT PROJECTS; PITUITARY ACTH HYPERSECRETION; RESPIRATORY MUSCLES;

EID: 79957703297     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1169     Document Type: Article

References (41)

1. Khaleeli AA, Edwards RH, Gohil K, McPhail G, Rennie MJ, Round J & Ross EJ. Corticosteroid myopathy: a clinical and pathological study. Clinical Endocrinology 1983 18 155-166. (doi:10.1111/j.1365-2265.1983.tb03198.x)
2. Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI & Chihara K. Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Hormone Research 2001 56 24-28. (doi:10.1159/000048130)
3. Owczarek J, Jasinska M & Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacological Reports 2005 57 23-34.
4. Dumitru D. Myopathies. In Electrodiagnostic Medicine, 1st edn, pp1031-1129. Ed.DDumitru.Philadelphia:Hanley&Belfus,1995.
5. Minetto MA, Botter A, Lanfranco F, Baldi M, Ghigo E & Arvat E. Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2010 95 1663-1671. (doi:10.1210/jc.2009- 2161)
6. van der Hoeven JH. Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy. Muscle and Nerve 1996 19 100-102. (doi:10.1002/(SICI)1097-4598(199601)19:1<100::AID-MUS16>3.0.CO;2- )
7. Mills GH, Kyroussis D, Jenkins P, Hamnegard CH, Polkey MI, Wass J, Besser GM, Moxham J & Green M. Respiratory muscle strength in Cushing's syndrome. American Journal of Respiratory and Critical Care Medicine 1999 160 1762-1765.
8. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A & Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
9. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G & McBurnie MA. Frailty in older adults: evidence for a phenotype. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2001 56 M146-M156. (Pubitemid 32187141)
10. Krupp LB, LaRocca NG, Muir-Nash J & Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 1989 46 1121-1123.
11. Single-joint system function. In Neuromechanics of Human Movement, 3rd edn, pp 241-321. Ed. RM Enoka. Champaign: Human Kinetics, 2002.
12. Farina D, Blanchietti A, Pozzo M & Merletti R. M-wave properties during progressive motor unit activation by transcutaneous stimulation. Journal of Applied Physiology 2004 97 545-555. (doi:10.1152/japplphysiol.00064.2004)
13. Botter A, Lanfranco F, Merletti R & Minetto MA. Myoelectric fatigue profiles during electrically-elicited contractions of vastus lateralis, vastus medialis obliquus, and vastus medialis longus muscles. International Journal of Sports Medicine 2009 30 408-417. (doi:10.1055/s-0028-1112142)
14. Andreassen S & Arendt-Nielsen L. Muscle fibre conduction velocity in motor units of the human anterior tibial muscle: a new size principle parameter. Journal of Physiology 1987 391 561-571. (Pubitemid 17161458)
15. Blijham PJ, Drost G, Stegeman DF & Zwarts MJ. Reduced musclefiber conduction but normal slowing after cold exposure in paramyotonia congenita. Muscle and Nerve 2008 37 23-26. (doi:10.1002/mus.20885)
16. Nandedkar SD & Stålberg E. Simulation of single muscle fibre action potentials. Medical and Biological Engineering and Computing 1983 21 158-165. (doi:10.1007/BF02441531)
17. Blijham PJ, ter Laak HJ, Schelhaas HJ, van Engelen BG, Stegeman DF & Zwarts MJ. Relation between muscle fiber conduction velocity and fiber size in neuromuscular disorders. Journal of Applied Physiology 2006 100 1837-1841. (doi:10. 1152/japplphysiol.01009.2005)
18. Merletti R, Fiorito A, Lo Conte LR & Cisari C. Repeatability of electrically evoked EMG signals in the human vastus medialis muscle. Muscle and Nerve 1998 21 184-193. (doi:10.1002/(SICI)1097-4598(199802)21:2〈184::AID- MUS5〉3.0.CO;2-7)
19. Rainoldi A, Gazzoni M, Merletti R & Minetto MA. Mechanical and EMG responses of the vastus lateralis and changes in biochemical variables to isokinetic exercise in endurance and power athletes. Journal of Sports Sciences 2008 26 321-331. (doi:10.1080/02640410701474499)
20. Knaflitz M, Merletti R & De Luca CJ. Inference of motor unit recruitment order in voluntary and electrically elicited contractions. Journal of Applied Physiology 1990 68 1657-1667. (Pubitemid 20151895)
21. Kamavuako EN & Farina D. Time-dependent effects of preconditioning activation on muscle fiber conduction velocity and twitch torque. Muscle & Nerve 2010 42 547-555. (doi:10.1002/mus.21726)
22. Brody LR, Pollock MT, Roy SH, De Luca CJ & Celli B. pH-induced effects on median frequency and conduction velocity of the myoelectric signal. Journal of Applied Physiology 1991 71 1878-1885.
23. Kupa EJ, Roy SH, Kandarian SC & De Luca CJ. Effects of muscle fiber type and size on EMG median frequency and conduction velocity. Journal of Applied Physiology 1995 79 23-32.
24. Bischoff C, Stålberg E, Falck B & Eeg-Olofsson KE. Reference values of motor unit action potentials obtained with multi-MUAP analysis. Muscle and Nerve 1994 17 842-851. (doi:10.1002/mus.880170803)
25. Sta° lberg E, Falck B, Sonoo M, Sta° lberg S & Aström M. Multi-MUP EMG analysis - a two year experience in daily clinical work. Electroencephalography and Clinical Neurophysiology 1995 97 145-154. (doi:10.1016/0924-980X(95)00007-8)
26. Stålberg E, Bischoff C & Falck B. Outliers, a way to detect abnormality in quantitative EMG. Muscle and Nerve 1994 17 392-399. (doi:10.1002/mus.880170406)
27. Motor unit potential studies. In Laboratory Reference for Clinical Neurophysiology, pp 418-431. Eds JA Livenson & MM Dong. New York: Oxford University Press, 1992.
28. Nandedkar SD, Barkhaus PE, Sanders DB & Stalberg EV. Analysis of amplitude and area of concentric needle EMG motor unit action potentials. Electroencephalography and Clinical Neurophysiology 1988 69 561-567. (doi:10.1016/0013-4694(88)90168-X)
29. Ramani V, Storey JR & Lava NS. Electrophysiological testing in neurological disorders: electroencephalography, evoked potentials, and electromyography. In A Guide to the Primary Care of Neurological Disorders, pp 87-97. Eds JA Popp & BI Tramer, New York: Thieme, 1998.
30. Henneman E, Somjen G & Carpenter DO. Functional significance of cell size in spinal motoneurons. Journal of Neurophysiology 1965 28 560-580.
31. Lexell J, Henriksson-Larsén K & Sjöström M. Distribution of different fibre types in human skeletal muscles. 2. A study of cross-sections of whole m. vastus lateralis. Acta Physiologica Scandinavica 1983 117 115-122. (doi:10.1111/j.1748-1716.1983.tb07185.x)
32. Travnik L, Pernus F & Erzen I. Histochemical and morphometric characteristics of the normal human vastus medialis longus and vastus medialis obliquus muscles. Journal of Anatomy 1995 187 403-411.
33. Stewart CR, Nandedkar SD, Massey JM, Gilchrist JM, Barkhaus PE & Sanders DB. Evaluation of an automatic method of measuring features of motor unit action potentials. Muscle and Nerve 1989 12 141-148. (doi:10.1002/mus. 880120209)
34. Fuglsang-Frederiksen A. The utility of interference pattern analysis. Muscle and Nerve 2000 23 18-36. (doi:10.1002/(SICI) 1097-4598(200001)23: 1〈18::AID-MUS4〉3.0.CO;2-B)
35. Finsterer J. EMG-interference pattern analysis. Journal of Electromyography and Kinesiology 2001 11 231-246. (doi:10.1016/S1050-6411(01) 00006-2)
36. Pino LJ, Stashuk DW, Boe SG & Doherty TJ. Probabilistic muscle characterization using QEMG: application to neuropathic muscle. Muscle and Nerve 2010 41 18-31. (doi:10.1002/mus.21456)
37. Blijham PJ, Hengstman GJ, Ter Laak HJ, van Engelen BG & Zwarts MJ. Muscle-fiber conduction velocity and electromyography as diagnostic tools in patients with suspected inflammatory myopathy: a prospective study. Muscle and Nerve 2004 29 46-50. (doi:10.1002/mus.10519)
38. Weber MA, Kinscherf R, Krakowski-Roosen H, Aulmann M, Renk H, Künkele A, Edler L, Kauczor HU & Hildebrandt W. Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting? Journal of Molecular Medicine 2007 85 887-896. (doi:10.1007/s00109-007- 0220-3)
39. Merletti R, Farina D, Gazzoni M & Schieroni MP. Effect of age on muscle functions investigated with surface electromyography. Muscle & Nerve 2002 25 65-76. (doi:10.1002/mus.10014)
40. Doherty TJ. Invited review: aging and sarcopenia. Journal of Applied Physiology 2003 95 1717-1727. (doi:10.1152/japplphysiol.00347.2003)
41. Inder WJ, Jang C, Obeyesekere VR & Alford FP. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1 - implications for steroid-induced myopathy. Clinical Endocrinology 2010 73 126-132. (doi:10.1111/j.1365-2265.2009.03683.x)